Leadership James Amatruda, MD, PhD Cancer and Blood Disease Institute Medical Oncology Expert Physicians Shahab Asgharzadeh, MD Cancer and Blood Disease Institute Neuroblastoma Deepa Bhojwani, MD Cancer and Blood Disease Institute Hematology Oncology Eric Chang, MD, FASTRO Cancer and Blood Disease Institute Radiation Oncology Yves DeClerck, MD Cancer and Blood Disease Institute Hematology Oncology Anat Erdreich-Epstein, MD, PhD Cancer and Blood Disease Institute Neuro-oncology Cecilia Fu, MD Cancer and Blood Disease Institute Hematology Oncology David Freyer, DO, MS Cancer and Blood Disease Institute Hematology Oncology Paul Gaynon, MD Cancer and Blood Disease Institute Hematology Oncology Emily Hsieh, MD Cancer and Blood Disease Institute Transplantation and Cellular Therapy Rima Jubran, MD, MPH, MACM Cancer and Blood Disease Institute Hematology Oncology Araz Marachelian, MD, MS Cancer and Blood Disease Institute Neuroblastoma Ashley Margol, MD, MS Cancer and Blood Disease Institute Neuro-oncology Arthur Olch, PhD, FAAPM Cancer and Blood Disease Institute Radiation Oncology Etan Orgel, MD, MS Cancer and Blood Disease Institute Hematology Oncology Nathan J. Robison, MD, MS Cancer and Blood Disease Institute Neuro-oncology David Tishler, MD Cancer and Blood Disease Institute Hematology Oncology Kenneth Wong, MD Cancer and Blood Disease Institute Radiation Oncology
Advice From Our Experts How to Talk to Your Child About Cancer in a Loved One April 25, 2025 Worried about what to say to your child when a loved one has cancer? A psychologist in CHLA’s Cancer and Blood Disease Institute shares tips for leading healthy conversations around cancer. Read more
Research and Breakthroughs CHLA Study Finds Aqueous Humor Liquid Biopsy is Safe for Children With Retinoblastoma April 15, 2025 CHLA study shows diagnostic procedure to extract aqueous humor in liquid biopsy is safe and well tolerated in children with retinoblastoma Read more
Work That Matters Research Trainee Spotlight: Shawn Barman March 14, 2025 PhD student Shawn Barman is working to develop a new generation of gated CAR-T cell to more effectively treat acute myeloid leukemia. Read more